The properdin pathway: an "alternative activation pathway" or a "critical amplification loop" for C3 and C5

Richard A Harrison1

  • 1Institute of Infection and Immunity, School of Medicine, Cardiff University, Henry Wellcome Building, Heath Park, Cardiff, CF14 4XN, UK. richard.alexander.harrison@outlook.com.

Seminars in Immunopathology
|November 24, 2017
PubMed

Insights

The alternative pathway of complement activation primarily amplifies C3 and C5, not just C3. This surface-dependent loop targets surfaces for elimination, crucial for understanding diseases and therapies.

Area of Science:

  • Immunology
  • Complement System Biology

Background:

  • The alternative pathway of complement activation is traditionally viewed as a distinct route for C3 activation.
  • Existing literature provides comprehensive reviews on the discovery and evolution of this pathway.

Purpose of the Study:

  • To contextualize current concepts of the alternative pathway.
  • To challenge the prevailing textbook view of the alternative pathway's primary role.
  • To propose the system's main function as a surface-dependent amplification loop for C3 and C5 activation.

Main Methods:

  • Literature review and conceptual analysis.
  • Re-evaluation of the established role of complement components.
  • Development of an argument for a revised understanding of the alternative pathway's function.

Main Results:

  • The alternative pathway's primary role is redefined as a surface-dependent amplification loop for C3 and C5 activation.
  • Surface deposition of C3b initiates a targeted elimination process.
  • A sophisticated amplification loop regulates the targeting and elimination of surfaces.

Conclusions:

  • The alternative pathway functions as a critical amplification loop for complement activation, targeting surfaces for elimination.
  • Understanding this amplification loop is essential for developing therapies for diseases linked to complement dysregulation.
  • Therapeutic strategies must address the complexities and challenges of modulating this amplification loop.

Related Concept Videos

Complement System01:27

Complement System

The complement system is a group of approximately 20 plasma proteins that strengthen the body's defenses against infections through opsonization, inflammation, and cell lysis. Opsonization involves coating pathogens with complement proteins, making them more recognizable and facilitating phagocyte engulfment. Certain complement proteins induce inflammation that attracts immune cells to the site of infection. Cell lysis involves the destruction of pathogens through the formation of a...
11.0K
Extrinsic and Intrinsic Pathways of Hemostasis01:20

Extrinsic and Intrinsic Pathways of Hemostasis

Blood clotting or coagulation involves extrinsic and intrinsic pathways, which ultimately merge into the common pathway, forming a fibrin clot.
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
13.4K
IP3/DAG Signaling Pathway01:11

IP3/DAG Signaling Pathway

Membrane lipids such as phosphatidylinositol (PI) are precursors for several membrane-bound and soluble second messengers. Specific kinases phosphorylate PI and produce phosphorylated inositol phospholipids. One such inositol phospholipids are the  phosphatidylinositol-4,5 bisphosphate [PI(4,5)P2], present in the inner half of the lipid bilayer. Upon ligand binding, GPCR stimulates Gq proteins to turn on phospholipase Cꞵ. Activated phospholipase Cꞵ cleaves PI(4,5)P2 and...
15.1K
Antigen Processing Pathways01:31

Antigen Processing Pathways

MHC molecules are key players in the immune response, enabling T cells to recognize and respond to specific antigens. They are present on the surface of all nucleated cells in the body and are instrumental in presenting antigens to T cells and activating them. T cells recognize the MHC-antigen complex and initiate an immune response. MHC class I and MHC class II are two main types of MHC molecules, each associated with a distinct antigen processing pathway.
MHC Class I: Presenting Endogenous...
2.4K
Amplifying Signals via Enzymatic Cascade01:22

Amplifying Signals via Enzymatic Cascade

When a ligand binds to a cell-surface receptor, the receptor's intracellular domain changes shape, which may either activate its enzyme function or allow its binding to other molecules. The initial signal is amplified by most signal transduction pathways. This means that a single ligand molecule can activate multiple molecules of a downstream target. Proteins that relay a signal are most commonly phosphorylated at one or more sites, activating or inactivating the protein. Kinases catalyze...
18.7K
Intracellular Signaling Cascades01:24

Intracellular Signaling Cascades

Once a ligand binds to a receptor, the signal is transmitted through the membrane and into the cytoplasm. The continuation of a signal in this manner is called signal transduction. Signal transduction only occurs with cell-surface receptors, which cannot interact with most components of the cell, such as DNA. Only internal receptors can interact directly with DNA in the nucleus to initiate protein synthesis. When a ligand binds to its receptor, conformational changes occur that affect the...
53.8K